Quantcast
Close Window
   
Welcome to 2018 :o)
As the lawsuits against Johnson & Johnson continue to pile up, looks like another year of the same Johnson & Johnson shit, unfettered by laws, regulations, ethics or even basic human compassion.
 
Just another year of bleeding people dry and then spitting out the corpse, slaughtering people faster than an ISIS wet dream.
 
Looks more and more like the biggest risk to Americans is Johnson & Johnson ;o)
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

 
This is INDEPENDENT, AD-FREE work that you are certainly NOT going to see in conventional media.
 
List of content exposing harm and corruption compiled since March of 2012
 
So far, as of January 19, 2018, there has been only ONE gift of support. Could use a little more help, please.
 
The people most at risk for harm by a known defective Johnson & Johnson product are those who can afford their outrageously priced products and those with health insurance; basically those who make over $100,000 per year.
 
If you'd like to help keep me writing, tweeting the information to Trump, US Senate, US Attorneys General, State Governors, US government health agencies such as FDA/CDC, etc, useless (fake) media, JNJ shareholders, it would be much appreciated if you would send a gift to help keep this effort going....
 
Next planned articles...
Done... Pharma Company Facing Over 108,000 Lawsuits Awarded $300 Million in Defense Department Contracts
 
On the list to do after I receive the next gift of support...
Kudos to Trump for Cutting Millions of Poor From Medicaid
Johnson & Johnson Innovative Population Control Strategy
Founder of Apotex and Wife Found Hung in Home Likely Visited JohnsonAndToxin Site Researching ....
Johnson & Johnson CEO Gorsky Wants to "CREATE A CRISIS"; gee, looks like he already did ;o)
 
Thank you,   
Emily
 
$.00         
 
JOHNSON & JOHNSON PARTIAL USA LAWSUIT LIST...
 
Baby powder ovarian cancer lawsuits
Metal-on-metal hip lawsuits
Xarelto DEATH and bleed-out lawsuits
Hernia and transvaginal mesh lawsuits
Invokana ketoacidosis, etc. lawsuits
Deadly, disabling Risperdal lawsuits
Deadly, disabling Levaquin lawsuits
* Velcade overcharging lawsuits
* Procrit heart attack lawsuits
* Stelera cancer lawsuits
* Morcellators uterine cancer lawsuits
* Tylenol death and liver failure lawsuits
* Defective diabetes device lawsuits
* Defective heart stent lawsuits
* Death and disability spine disc lawsuits
* Deadly bone cement lawsuits "Pigs injected with the cement died within minutes"
* Deadly, disabling opioid lawsuits
* Defective knee lawsuits
* Defective elbow lawsuits
* Deadly defective surgical tool lawsuits
* Topamax birth defect and suicide lawsuits
 
* NEW: January 2, 2018, CLASS ONE RECALL of heart device
 
This list is NOT all-inclusive and covers ONLY lawsuits in the United States.
 
* NOT mentioned on 2017 3rd 1/4 10Q

Glad to see you :o)
Notable visitors to the web site include:
 
US GOVERNMENT:
United States Air Force
US Senate
US Department of Defense
US Department of Justice
US Homeland Security
US Centers for Disease Control
 
GLOBAL FINANCIAL INSTITUTIONS:
Vanguard
Barclays
The Bank of New York Mellon Corp
Lloyds Banking Group PLC
Royal Bank of Canada
Bank of America
Harris Trust & Savings Bank
Deutsche Bank
Macquarie Bank
PNC Bank
Crédit Agricole Bank
Royal Bank of Scotland
Raymond James Financial
BlackRock Financial Management
...and many, many more from all over the world ;o)
 
Feel free to browse list of notable visitors to the web site.
 

Johnson & Johnson Financial BS Officer, I mean Vice Prez of Finance and Chief Financial Officer, Dominic Caruso
Our buddy Dom's career includes highlights such as 30% physician kickback for prescribing Remicade, allowing McNeil fall into filth and rubble to be shut down by FDA, massive recalls due to his obvious inability to manage a business.

Keywords: dominic, caruso, johnson & johnson, chief, financial, finance, centocor, remicade
Date Created/Edited: February 2, 2015
 

Most Recent Content....
Pharma Company Facing Over 108,000 Lawsuits Awarded $300 Million in Defense Department Contracts
Nothing like the best for United States Veterens, eh?
 
Johnson & Johnson Adds Another Two Thousand Lawsuits in Third Quarter 2017
Lawsuits against Johnson & Johnson continue to spiral out of control - breaking over 108,000 in third quarter 2017, with numerous unmentioned products also racking up an untold number of lawsuits not mentioned in 2017 10-Q.
 
History of Johnson & Johnson Janssen Fentanyl
Hmm, looks like Johnson & Johnson is profiting from BOTH sides of opioid addiction crisis ;o)
 
15 Steps to Solve Healthcare Crisis
How about this for a rough outline of a strategy to dramatically reduce healthcare costs?
 
ACA the Affordable CORRUPTION Act
The only purpose of the ACA/ObamaCare was to force everyone to pay legal fees and victim settlements and care from harm by Johnson & Johnson.
 
Johnson & Johnson Begs US FDA to Expand Xarelto Slaughter
After killing around 2,000 people in the United States in 2016 alone, Johnson & Johnson wants to spread the deaths even more!
 
Johnson & Johnson Facing Over $100 BILLION in Lawsuit Debt
With a flood of lawsuits pouring in from around the world, Johnson & Johnson is facing at least $100 BILLION lawsuit debt.
 
The Johnson & Johnson Drugged Kids Pension Plan
Teacher and state retirement funds invest in Johnson & Johnson, the DRUGGED KIDS PENSION PLAN
 
Second Quarter 2017 Lawsuits Against Johnson & Johnson
Lawsuits against Johnson & Johnson in United States holding at 106,600! DOES NOT INCLUDE ALL PRODUCTS FACING LAWSUITS OR LAWUITS FILED OUTSIDE THE UNITED STATES!
 
Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Why President Trump Should Shut Down US FDA (2017, March 28)
Healthcare organizations around the world depend on US FDA decisions, however, profit, rather than safety, seems to be the primary motivation.
healthcare, health, obamacare, donald, trump, fda, fraud, kickback
 
The Difference Between Guinea Pig and Cash Cow (2016, September 27)
People keep saying pharma is using us as 'guinea pigs'. Uh, not quite. Take a minute to learn the difference between a 'guinea pig' and a 'cash cow'.
guinea pig, immunization, vaccination, profit, harm, autism, disability, asthma
 
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
According to Dominic Caruso's Bio on the Johnson & Johnson web site, Dominic earned a B.S. degree in business administration from Drexel University. And then...
 
Prior to joining Centocor in 1985, Dominic got his unique talents at KPMG, one of the Big 4 accounting firms. Seems one of the specialties of that firm is to get major corporations out of paying taxes.
 
In 1985, Dominic brought his amazing accounting talents to Centocor. Centocor was bought by Johnson & Johnson in 1999. Caruso was part of the package and continue working for Centocor, now a subsidiary of Johnson & Johnson. Interestingly, he was obviously oblivious to accounting warning signs regarding the 30% more charged to health care system to give doctors a 30% kickback for writing prescriptions for Remicade. Geeze, not exactly paying much attention to detail, eh?
 
Rather than remove an obviously ineffective accountant from the finance system of Johnson & Johnson who was unable to detect obvious financial fraud, Dominic Caruso was actually promoted to financial responsibilities of Ortho-McNeil in 2001 and amazingly was put on the management board for the subsidiary.
 
Since this guy is obviously far better bullshitting people than handling accounting responsibilities for a global company it's not much of a challenge to figure out what would, and did, happen next.
 
Most people would believe that Caruso would be a little more on the look-out for fraud to prevent additional damage to his reputation and the reputation of Johnson & Johnson. But, obviously the lesson was missed as Dominic didn't notice a similar scam by Ottho-McNeil-Janssen with off-label promotion and illegal billing through Medicaid and other social programs for Topomax. I wonder if he knew that, at that time, Gorsky was running the off-label OmniCare Risperdal scandal at Janssen? Hm. Two scams running to steal from Medicaid at one time - and we wonder WHY the high cost of healthcare? Duh.
 
Again, the obvious right choice for an ethical company regarding continued inability of a financial manager to notice and alert upper management to fraud in his unit would have been to terminate his employment to protect the image of the company. However, again he was promoted ;o)
 
In May of 2003 Dominic was promoted to Vice President, Group Finance for Johnson & Johnson's Medical Devices and Diagnostics Group, and added as a member of the Medical Devices and Diagnostics Group Operating Committee. This is the department that had 93,000 defective hips go out, on the market, into people and then recalled without compensation to the victims. Massive lawsuits are pouring in from all over the world regarding these known defective products.
 

Dominic would have been in a decision-making role in choosing to pull the known defective devices or continue selling them until suppies were deleted. Well, since the hips are all over the world, if he had any protest, it was over-ruled. This is also the department responsible for continuing the sale and implantation of known defective vaginal mesh. Again, since he is a member of the Medical Devices and Diagnostic Operating Committee, he has a vote in how long the company will continue to increase victims from this horrendous, debilitating product. Another product with massive lawsuits pouring in from all around the world.
 
Well, it seems his silence with regard to corruption and lack of concern for the health and safety of consumers, I mean incredible accounting skills and adherence to the Johnson & Johnson Credo, brought yet another promotion. In December of 2005 Caruso was given responsibility for the Company's Group Finance organization.
 
While Dominic was in control of the money at Johnson & Johnson, salaries soared, stock price and dividends increased while consumers were being financially destroyed by skyrocketing healthcare prices, massive job cuts and conditions of the McNeil facility deteriorated to the point of being shut down by the FDA for non-compliance with numerous regulations intended to *prevent* risks to consumers. The subsidiary lacked funding so bad that it literally crumbled into a pit of FDA warnings for lack of equipment service and maintenance, not handling customer complaints and a string of recalls beyond belief. The reasons for FDA inspections is to ensure compliance with regulations intended to protect consumers. FDA regulations are really not a big deal for an ethical company. Basically, maintain equipment, develop motivated employees, maintain a clean workplace, value customer feedback as a tool for growth and ensure a zero-tolerance quality control program to ensure consumer satisfaction and safety. Again, common sense and not a big deal for an existing product line or manufacturing facility.
 
The incredible failure of responsible financial management of Johnson & Johnson that caused dozens of recalls, dozens of FDA Warnings and ultimate closure of one facility and two others operating under FDA Consent Decree was the basis for a shareholder lawsuit against the company filed in 2011. Named Defendants include: William C. Weldon, Dominic J. Caruso, Colleen A. Goggins and Peter Luther. The Shareholders didn't get the requested jury trial, all they got was a settlement of $23 million.
 
Finally, after being blind to corruption-driven profit such as 30% physician kickbacks, illegal billing for Medicaid and healthcare products, lack of concern for well-being of consumers AND not being able to manage money well enough to prevent a subsidiary from crumbling into a pit of FDA Warnings so deep the FDA had to take over three facilities, which are *still* running under FDA Consent Decree, Dominic Caruso continues in his role of Vice President, Finance and Chief Financial Officer of Johnson & Johnson, as per his 2007 promotion.
 
Am I really the only person that finds this outrageous?
 
Resources:
1. Johnson & Johnson Staff (Current). Management Team Dominic J. Caruso Biography. Johnson & Johnson Web Site. Retrieved from http://www.investor.jnj.com/governance/managementdetail.cfm?bioid=19177
 
2. SCO Blog Writer (2007, February 22). Remicade: deceptive pricing, federal lawsuits--and a movie. SCO Recipe Blog. Retrieved from http://blog.scdrecipe.com/blog/2007/02/22/remicade-deceptive-pricing-federal-lawsuits-and-a-movie
 
3. PRNewsWire (2004?, April 29). Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million. Bloomberg. Retrieved from http://www.bloomberg.com/apps/news?pid=conewsstory&tkr=JNJC:AR&sid=aTGtM8shNIWI
 
4. Emily Patterson (2012, April 13). Johnson & Johnson Risperdal: Broken Laws and Side Effects. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/risperdal.shtml
 
5. Parija Kavilanz (2011, March 10). U.S. takes over three Tylenol plants. Money.CNN.com. Retrieved from http://money.cnn.com/2011/03/10/news/companies/johnson_mcneil_fda_action/index.htm
 
6. University of Denver (2012, April 16). United States District Court, District of New Jersey, Civil Action No. 10-4841 (FLW)(DEA). University of Denver. Retrieved from http://www.law.du.edu/documents/corporate-governance/securities-matters/monk/Amended-Complaint-and-Demand-for-Jury-Trial-Monk-v-Johnson-Johnson-No-10-4841-FLW-2013-WL-436514-D-N-J-Feb-5-2013.pdf
 
7. Emily Patterson (2013, July 19). Johnson & Johnson Pacifies Shareholder Lawsuit with Pathetic $23 Million. Johnson and Toxin. Retrieved from http://www.johnsonandtoxin.com/jnj_shareholder_settlement.shtml
 
All contents Copyright © 2012-2017 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries